134 related articles for article (PubMed ID: 17073682)
1. PET imaging of norepinephrine transporters.
Ding YS; Lin KS; Logan J
Curr Pharm Des; 2006; 12(30):3831-45. PubMed ID: 17073682
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
Ding YS; Lin KS; Logan J; Benveniste H; Carter P
J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
[TBL] [Abstract][Full Text] [Related]
3. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
Logan J; Ding YS; Lin KS; Pareto D; Fowler J; Biegon A
Nucl Med Biol; 2005 Jul; 32(5):531-42. PubMed ID: 15982584
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs.
Ding YS; Lin KS; Garza V; Carter P; Alexoff D; Logan J; Shea C; Xu Y; King P
Synapse; 2003 Dec; 50(4):345-52. PubMed ID: 14556239
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.
Severance AJ; Milak MS; Kumar JSD; Prabhakaran J; Majo VJ; Simpson NR; Van Heertum RL; Arango V; Mann JJ; Parsey RV
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):688-693. PubMed ID: 17180600
[TBL] [Abstract][Full Text] [Related]
6. Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.
Schou M; Pike VW; Halldin C
Curr Top Med Chem; 2007; 7(18):1806-16. PubMed ID: 17979789
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.
Ding YS; Singhal T; Planeta-Wilson B; Gallezot JD; Nabulsi N; Labaree D; Ropchan J; Henry S; Williams W; Carson RE; Neumeister A; Malison RT
Synapse; 2010 Jan; 64(1):30-8. PubMed ID: 19728366
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.
Schou M; Sóvágó J; Pike VW; Gulyás B; Bøgesø KP; Farde L; Halldin C
Mol Imaging Biol; 2006; 8(1):1-8. PubMed ID: 16322935
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.
Zeng F; Jarkas N; Stehouwer JS; Voll RJ; Owens MJ; Kilts CD; Nemeroff CB; Goodman MM
Bioorg Med Chem; 2008 Jan; 16(2):783-93. PubMed ID: 17983754
[TBL] [Abstract][Full Text] [Related]
10. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.
Gallezot JD; Weinzimmer D; Nabulsi N; Lin SF; Fowles K; Sandiego C; McCarthy TJ; Maguire RP; Carson RE; Ding YS
Neuroimage; 2011 May; 56(1):268-79. PubMed ID: 20869448
[TBL] [Abstract][Full Text] [Related]
12. Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand.
Hwang JJ; Yeckel CW; Gallezot JD; Aguiar RB; Ersahin D; Gao H; Kapinos M; Nabulsi N; Huang Y; Cheng D; Carson RE; Sherwin R; Ding YS
Metabolism; 2015 Jun; 64(6):747-55. PubMed ID: 25798999
[TBL] [Abstract][Full Text] [Related]
13. PET Quantification of the Norepinephrine Transporter in Human Brain with (
Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
[TBL] [Abstract][Full Text] [Related]
14. Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
Li CS; Potenza MN; Lee DE; Planeta B; Gallezot JD; Labaree D; Henry S; Nabulsi N; Sinha R; Ding YS; Carson RE; Neumeister A
Neuroimage; 2014 Feb; 86():306-10. PubMed ID: 24121204
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo and in vivo evaluation of the norepinephrine transporter ligand [11C]MRB for brown adipose tissue imaging.
Lin SF; Fan X; Yeckel CW; Weinzimmer D; Mulnix T; Gallezot JD; Carson RE; Sherwin RS; Ding YS
Nucl Med Biol; 2012 Oct; 39(7):1081-6. PubMed ID: 22595487
[TBL] [Abstract][Full Text] [Related]
16. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
[TBL] [Abstract][Full Text] [Related]
17. Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.
Comley RA; Salinas CA; Slifstein M; Petrone M; Marzano C; Bennacef I; Shotbolt P; Van der Aart J; Neve M; Iavarone L; Gomeni R; Laruelle M; Gray FA; Gunn RN; Rabiner EA
J Pharmacol Exp Ther; 2013 Aug; 346(2):311-7. PubMed ID: 23685546
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
